Funding for Healthtech companies falls 55% to $1.4 bn in 2022: Tracxn

Drop is mostly due to a 75% dip in late-stage investments, from $2.4 billion in 2021 to $606 million in 2022

Healthcare
Aryaman Gupta New Delhi
2 min read Last Updated : Mar 29 2023 | 11:17 PM IST
Funding for health technology companies fell 55 per cent to $1.4 billion in 2022, from to $3.2 billion in 2021 amid the ongoing funding winter in the Indian start-up ecosystem, said a recent report.

This drop is mostly due to a massive 75 per cent dip in late-stage investments, which went from $2.4 billion in 2021 to $606 million in 2022, according to the report by Tracxn, a market intelligence platform.

Despite the decline, 2022 was still the second-highest funded year in the past decade, after 2021. The pandemic, the report says, has made people more aware of the importance of health, which led to the greater use of digital health services and drove growth in this space.



Source:Tracxn

While investor interest in the HealthTech sector skyrocketed in the pandemic period, the space started experiencing a declining trend in funding from Q4 of 2021. Due to the funding winter, current macroeconomic conditions, and rising interest rates, investors across the globe have become more cautious in spending their money. This trend has been observed in the HealthTech sector as well.

Online pharmacy Tata 1mg was the only Indian HealthTech company to become a unicorn in 2022. The company raised $40.8 million in a round led by Tata Digital, with participation from KWE Beteiligungen AG, HBM Healthcare Investments and others. This raised the company’s valuation to $1.3 billion, making it a unicorn.

Only two funding rounds valued over $100 million took place in 2022, compared to 10 during the previous year. Digital healthcare platform MediBuddy raised $125 million in a Series C funding round from Quadria Capital, Lightrock India and others. Consumer nutrition platform HealthKart was the other who raised $135 million in a Series H round from Temasek, A91 Partners and others.

Despite this downturn, higher digital adoption and favourable government policies are expected to increase the activity in this space. Advancement in technologies like AI, robotics, cloud computing, data analytics, and IoT are also expected to improve the Indian HealthTech sector.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Healthtech start-upfundingstart- ups

First Published: Mar 29 2023 | 6:00 PM IST

Next Story